Research teams from the Kaiser Permanente Division of Research and the University of Michigan have been granted a total of $10.5 million by the American Heart Association to study the application of artificial intelligence (AI) in improving cardiovascular disease screening and treatment. This initiative underscores the growing importance of AI in healthcare, particularly in addressing the leading cause of death in the U.S.
The Kaiser Permanente team, led by Dr. David Ouyang, will focus on utilizing AI to expand the diagnostic capabilities of echocardiograms. These heart ultrasounds, which are cost-effective and radiation-free, can also reveal conditions in nearby organs like the liver and kidneys. The project aims to develop AI technology that can detect early signs of kidney and liver disease during heart scans, facilitating timely intervention and reducing cardiovascular complications.
Meanwhile, the University of Michigan's research, under Dr. Cindy Hsu's leadership, will explore AI's potential to personalize CPR for sudden cardiac arrest patients. By integrating an AI algorithm with a wearable sensor, the team hopes to provide real-time blood pressure monitoring during CPR, enabling emergency responders to adjust their techniques for optimal patient outcomes.
These projects highlight the critical role of AI in transforming healthcare delivery. With cardiovascular disease claiming millions of lives annually, the integration of AI into diagnostic and treatment processes could significantly enhance patient care and survival rates. The American Heart Association's investment in these studies reflects its commitment to advancing medical research and improving global health outcomes.
